3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
8
Neoplasm Metastasis
5
Ovarian Neoplasms
4
Neoplasms
3
Multiple Myeloma
3
Metastatic Castration-resistant Prostate Cancer
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lymphoma, B-Cell
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Recurrence
1
Prostate Cancer Metastatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oral Ulcer
1
Myasthenia Gravis
1
Metastatic Castration-Resistant Prostate Cancer Patients
1
Metastatic Castration-Resistant Prostate Cancer
1
Hodgkin Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
ravulizumab
1
Prednisone
1
Prednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Adrenal Insufficiency
×
Prednisolone
×
Clear all
NCT07221838
2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4
Recruiting
75 enrolled